KFAS
GMED icon

Keating Financial Advisory Services’s Globus Medical GMED Stock Holding History

Keating Financial Advisory Services’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74K Sell
22
-17
-44% -$1.45K ﹤0.01% 1993
2026
Q1 		$3.36K Buy
39
+8
+26% +$718 ﹤0.01% 1621
2025
Q4 		$2.71K Buy
+31
New +$2.35K ﹤0.01% 1490

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Keating Financial Advisory Services's GMED Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Globus Medical (GMED) stake by 44% in Q2 2026, selling an estimated $1.45K and leaving 22 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Keating Financial Advisory Services first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.36K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Keating Financial Advisory Services held 22 shares of Globus Medical worth $1.74K as of Q2 2026.
  • Keating Financial Advisory Services sold 17 Globus Medical shares in Q2 2026, an estimated $1.45K.
  • Globus Medical made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1993 holding.
  • Keating Financial Advisory Services first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Globus Medical position peaked at $3.36K in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.